Phibro Animal Health Co. (NASDAQ:PAHC) Receives Consensus Rating of “Strong Sell” from Analysts

Phibro Animal Health Co. (NASDAQ:PAHC) has received an average rating of “Strong Sell” from the five analysts that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a sell rating and two have issued a hold rating on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $15.00.

PAHC has been the subject of a number of recent research reports. Bank of America raised their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research note on Friday, August 30th. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective for the company.

Phibro Animal Health Stock Performance

PAHC opened at $21.31 on Friday. Phibro Animal Health has a twelve month low of $9.40 and a twelve month high of $22.84. The firm has a market capitalization of $863.12 million, a PE ratio of 66.59, a PEG ratio of 1.77 and a beta of 0.52. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79. The firm’s 50-day moving average price is $20.04 and its 200 day moving average price is $17.52.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.07. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. The business had revenue of $273.16 million for the quarter, compared to analysts’ expectations of $262.44 million. As a group, sell-side analysts expect that Phibro Animal Health will post 1.44 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Wednesday, September 4th were paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.25%. The ex-dividend date was Wednesday, September 4th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 150.00%.

Insider Transactions at Phibro Animal Health

In related news, Director E Thomas Corcoran acquired 5,000 shares of Phibro Animal Health stock in a transaction that occurred on Wednesday, September 4th. The shares were purchased at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the acquisition, the director now owns 25,000 shares in the company, valued at approximately $500,500. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 50.06% of the company’s stock.

Institutional Trading of Phibro Animal Health

Institutional investors have recently added to or reduced their stakes in the stock. CWM LLC boosted its position in shares of Phibro Animal Health by 89.8% during the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after buying an additional 1,035 shares during the period. Fidelis Capital Partners LLC acquired a new position in Phibro Animal Health during the 1st quarter worth about $46,000. China Universal Asset Management Co. Ltd. boosted its holdings in Phibro Animal Health by 65.0% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock valued at $50,000 after acquiring an additional 1,531 shares during the period. Summit Securities Group LLC acquired a new position in Phibro Animal Health in the 2nd quarter valued at about $83,000. Finally, Illinois Municipal Retirement Fund increased its stake in Phibro Animal Health by 7.2% during the first quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock worth $148,000 after purchasing an additional 765 shares during the period. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.